BEVESPI AEROSPHERE

This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug BEVESPI AEROSPHERE contains a combination of these active pharmaceutical ingredients (APIs):

1 Glycopyrronium UNII V92SO9WP2I - GLYCOPYRROLATE

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways. Read about Glycopyrronium

2 Eformoterol UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. Read about Eformoterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BEVESPI AEROSPHERE Pressurised inhalation, suspension	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AL07		R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1786596, 1831384
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 124662, 415060
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 393292
Country: JP	医薬品医療機器総合機構	Identifier(s): 2259808G1020, 2259808G2027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086876, 1088672
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 200271
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100416810
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65410001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699786520035
Country: US	FDA, National Drug Code	Identifier(s): 0310-4600